| Numéro |
Therapie
Volume 68, Numéro 6, Novembre-Décembre 2013
|
|
|---|---|---|
| Page(s) | 409 - 410 | |
| Section | Lettres à la Rédaction/Letters to Editor | |
| DOI | https://doi.org/10.2515/therapie/2013060 | |
| Publié en ligne | 11 novembre 2013 | |
Two Cases of Recurrent Priapism during Antineoplastic Chemotherapy: Think about Ondansetron
Deux cas de priapisme avec réinduction positive durant une chimiothérapie anticancéreuse : penser à l’ondansétron
1
Regional Pharmacovigilance Center, University Hospital of
Nancy, Nancy,
France
2
Clinic of Gentilly, Department of Oncology, Nancy, France
3
Department of Clinical PharmacologyUniversity Hospital of
Nancy, Nancy,
France
Correspondence and offprints:
Philippe Trechot, Department of Clinical Pharmacology, University
Hospital of Nancy, 29 avenue de Lattre de Tassigny, 54035 Nancy Cedex, France. Email:
p.trechot@chu-nancy.fr
Received:
28
June
2013
Accepted:
16
July
2013
These two cases have been declared to the Regional Pharmacovigilance Center of
Lorraine, Nancy, France (September 22th, 2010 for case n° 1 ; June 26th, 2011 for case
n° 2)
This article has no abstract.
Key words: priapism / 5-HT3-receptor antagonists / ondansetron / drug-induced
Mots clés : priapisme / antagonistes des récepteurs 5-HT3 / ondansétron / effet indésirable
© 2013 Société Française de Pharmacologie et de Thérapeutique
